Other analysts also recently issued reports about the company. JPMorgan Chase & Co. restated a “neutral” rating on shares of Johnson Matthey in a report on Thursday, July 8th. Zacks Investment Research downgraded Johnson Matthey from a “hold” rating to a “sell” rating in a report on Wednesday, August 4th. Panmure Gordon raised shares of Johnson Matthey from a “sell” rating to a “hold” rating in a research report on Wednesday, July 7th. Berenberg Bank raised shares of Johnson Matthey to a “buy” rating in a research report on Friday, June 4th. Finally, Jefferies Financial Group reaffirmed a “buy” rating on shares of Johnson Matthey in a research report on Wednesday, June 2nd. Four analysts have rated the stock with a sell rating, four have issued a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $91.98.
JMPLY stock opened at $71.07 on Monday. The company has a market cap of $6.88 billion, a price-to-earnings ratio of 15.51, a PEG ratio of 1.03 and a beta of 1.45. The company has a quick ratio of 0.85, a current ratio of 1.35 and a debt-to-equity ratio of 0.47. The business has a fifty day simple moving average of $82.91 and a 200-day simple moving average of $86.68. Johnson Matthey has a 52 week low of $55.18 and a 52 week high of $95.72.
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Recommended Story: High-Yield Dividend Stocks
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.